FILSUVEZ is for the treatment of wounds associated with dystrophic and junctional epidermolysis bullosa (EB) in adult and pediatric patients 6 months of age and older.
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-filsuvez
No hay comentarios:
Publicar un comentario